Die Häufigkeit hepatotoxischer Nebenwirkungen der tuberkulostatischen Kombinationstherapie (INH, RMP, EMB) in Abhängigkeit vom Acetyliererphänotyp
- 1 May 1982
- journal article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 60 (10) , 513-519
- https://doi.org/10.1007/bf01756097
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Maximaler Induktionszeitpunkt und Induktionsdauer arzneimittelabbauender Enzyme beim Menschen nach Gaben von RifampicinVerhandlungen der Deutschen Gesellschaft für innere Medizin, 1978
- Adverse reactions to rifampicin in antituberculosis regimensJournal of Antimicrobial Chemotherapy, 1977
- Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong KongTubercle, 1976
- Pharmacokinetics of isoniazid metabolism in manJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Isoniazid Liver Injury: Clinical Spectrum, Pathology, and Probable PathogenesisAnnals of Internal Medicine, 1976
- RIFAMPICIN HEPATITISThe Lancet, 1974
- Co-operative controlled trial of a standard regimen of streptomycin,pas and isoniazid and three alternative regimens of chemotherapy in Britain A report from the British Medical Research CouncilTubercle, 1973
- Toxicity from rifampicin plus isoniazid and rifampicin plus ethambutol therapyTubercle, 1971
- Kinetic Studies on RifampicinChemotherapy, 1971
- Sulphadimidine Acetylation Test for Classification of Patients as Slow or Rapid Inactivators of IsoniazidBMJ, 1970